1. Home
  2. Labeler Index
  3. Novadoz Pharmaceuticals Llc
  4. 72205-037
  5. Product Images: Levetiracetam

Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 72205-037 by Novadoz Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bottle-label - bottle label

bottle-label - bottle label

Levetiracetam is a medication that comes in oral form and is typically used in accordance with the directions provided on the package insert. This drug is distributed by Novadoz Pharmaceuticals LLC and is available in 100 mg/mL strength. Proper storage is crucial and it should be kept at a temperature range of 20°C to 25°C (68°F to 77°F), with brief excursions to 15°C to 30°C (59°F to 86°F) allowed as per USP Controlled Room Temperature guidelines. This medication should be kept out of the reach of children and dispensed by a pharmacist in a light-resistant, tight container with a child-resistant closure. Manufacturing details indicate that it is produced by MSN Pharmaceuticals Inc.*

figure-1 - figure 1

figure-1 - figure 1

This text is a comparison between the effects of placebo and two different doses of a medication called Levetiracetam in two groups of different sizes (95 and 97 in the placebo group, and 101 in the Levetiracetam 3000mg/day group).*

figure-2 - figure 2

figure-2 - figure 2

figure-3 - figure 3

figure-3 - figure 3

This is the result of a clinical trial that compared the response of patients taking a placebo (104 individuals) versus those taking a 3000 mg/day dose of Levetiracetam (180 individuals). The percentages indicate the proportion of patients that experienced the desired effect, but the nature of this effect is not available.*

figure-4 - figure 4

figure-4 - figure 4

This text appears to be showing the percentage of patients in a study who were given a placebo (44.6%) and those who were given levetiracetam (19.6%). The number of patients for each group is also provided (97 for placebo and 101 for levetiracetam). It is likely that this information is being used to compare the effectiveness of the placebo and levetiracetam in treating a particular condition, but without more context it is impossible to say for certain.*

figure-5 - figure 5

figure-5 - figure 5

figure-6 - figure 6

figure-6 - figure 6

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.